• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

S1P(4)受体介导 S1P 诱导的正常血压和高血压大鼠肺血管收缩。

S1P(4) receptor mediates S1P-induced vasoconstriction in normotensive and hypertensive rat lungs.

机构信息

Department of Pharmacology and Internal Medicine, and Center for Lung Biology, University of South Alabama College of Medicine, Mobile, Alabama, USA.

出版信息

Pulm Circ. 2011 Jul-Sep;1(3):399-404. doi: 10.4103/2045-8932.87309.

DOI:10.4103/2045-8932.87309
PMID:22140630
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3224432/
Abstract

This study aimed to identify receptors mediating sphingosine-1-phosphate (S1P)-induced vasoconstriction in the normotensive and chronic hypoxia-induced hypertensive rat pulmonary circulation. In isolated perfused lungs from normoxic rats, infusion of S1P caused a sustained vasoconstriction, which was not reduced by combinational pretreatment with the dual S1P(1 and 3) receptor antagonist VPC23019 and the S1P(2) receptor antagonist JTE013. The S1P(4) receptor agonists phytosphingosine-1-phospate and VPC23153, but not the dual S1P(1 and 3) receptor agonist VPC24191, caused dose-dependent vasoconstrictions. In hypertensive lungs from chronically hypoxic rats, the vasoconstrictor responses to S1P and VPC23153 were markedly enhanced. The S1P(4) receptor agonist VPC 23153 caused contraction of isolated pulmonary but not of renal or mesenteric arteries from chronically hypoxic rats. S1P(4) receptor protein as well as mRNA were detected in both normotensive and hypertensive pulmonary arteries. In contrast to what has been reported in the systemic circulation and mouse lung, our findings raise the possibility that S1P(4) receptor plays a significant role in S1P-induced vasoconstriction in the normotensive and hypertensive rat pulmonary circulation.

摘要

本研究旨在鉴定介导鞘氨醇-1-磷酸(S1P)诱导的正常血压和慢性低氧诱导的高血压大鼠肺循环血管收缩的受体。在来自正常氧合大鼠的离体灌注肺中,S1P 的输注引起持续的血管收缩,联合预处理双重 S1P(1 和 3)受体拮抗剂 VPC23019 和 S1P(2)受体拮抗剂 JTE013 并不能减轻这种收缩。S1P(4)受体激动剂植物鞘氨醇-1-磷酸和 VPC23153 引起剂量依赖性的血管收缩,但双重 S1P(1 和 3)受体激动剂 VPC24191 则没有。在慢性低氧大鼠的高血压肺中,S1P 和 VPC23153 的血管收缩反应明显增强。S1P(4)受体激动剂 VPC 23153 引起慢性低氧大鼠离体肺血管收缩,但对肾或肠系膜动脉没有收缩作用。S1P(4)受体蛋白和 mRNA 均在正常血压和高血压肺血管中检测到。与在体循环和小鼠肺中报道的情况相反,我们的研究结果表明,S1P(4)受体在正常血压和高血压大鼠肺循环中 S1P 诱导的血管收缩中可能发挥重要作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9765/3224432/2ac49e6aaeb8/PC-1-399-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9765/3224432/d513c99a3aba/PC-1-399-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9765/3224432/fa0d80f9dead/PC-1-399-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9765/3224432/2ac49e6aaeb8/PC-1-399-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9765/3224432/d513c99a3aba/PC-1-399-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9765/3224432/fa0d80f9dead/PC-1-399-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9765/3224432/2ac49e6aaeb8/PC-1-399-g003.jpg

相似文献

1
S1P(4) receptor mediates S1P-induced vasoconstriction in normotensive and hypertensive rat lungs.S1P(4)受体介导 S1P 诱导的正常血压和高血压大鼠肺血管收缩。
Pulm Circ. 2011 Jul-Sep;1(3):399-404. doi: 10.4103/2045-8932.87309.
2
Analysis of sphingosine 1-phosphate receptors involved in constriction of isolated cerebral arteries with receptor null mice and pharmacological tools.利用基因敲除小鼠和药理学工具分析参与离体脑动脉收缩的1-磷酸鞘氨醇受体。
Br J Pharmacol. 2008 Jan;153(1):140-7. doi: 10.1038/sj.bjp.0707581. Epub 2007 Nov 19.
3
EDRF suppresses an unidentified vasoconstrictor mechanism in hypertensive rat lungs.内皮舒张因子抑制高血压大鼠肺中一种不明的血管收缩机制。
Am J Physiol. 1993 Jun;264(6 Pt 1):L587-97. doi: 10.1152/ajplung.1993.264.6.L587.
4
Sphingosine 1-phosphate (S1P) regulates vascular contraction via S1P3 receptor: investigation based on a new S1P3 receptor antagonist.鞘氨醇 1-磷酸(S1P)通过 S1P3 受体调节血管收缩:基于新型 S1P3 受体拮抗剂的研究。
Mol Pharmacol. 2010 Apr;77(4):704-13. doi: 10.1124/mol.109.061481. Epub 2010 Jan 22.
5
Endothelin-1 mediates nitro-L-arginine vasoconstriction of hypertensive rat lungs.内皮素-1介导高血压大鼠肺脏的硝基-L-精氨酸血管收缩。
Am J Physiol. 1997 May;272(5 Pt 1):L807-12. doi: 10.1152/ajplung.1997.272.5.L807.
6
Endothelin receptors mediating contraction of rat and human pulmonary resistance arteries: effect of chronic hypoxia in the rat.介导大鼠和人肺阻力动脉收缩的内皮素受体:慢性低氧对大鼠的影响。
Br J Pharmacol. 1998 Apr;123(8):1621-30. doi: 10.1038/sj.bjp.0701785.
7
Thapsigargin stimulates increased NO activity in hypoxic hypertensive rat lungs and pulmonary arteries.
J Appl Physiol (1985). 1996 Apr;80(4):1336-44. doi: 10.1152/jappl.1996.80.4.1336.
8
S1P2 receptor-dependent Rho-kinase activation mediates vasoconstriction in the murine pulmonary circulation induced by sphingosine 1-phosphate.鞘氨醇 1-磷酸诱导的小鼠肺循环血管收缩由 S1P2 受体依赖性 Rho 激酶激活介导。
Am J Physiol Lung Cell Mol Physiol. 2010 Jul;299(1):L137-45. doi: 10.1152/ajplung.00233.2009. Epub 2010 Apr 30.
9
Endothelin-1 and serotonin are involved in activation of RhoA/Rho kinase signaling in the chronically hypoxic hypertensive rat pulmonary circulation.内皮素-1和5-羟色胺参与慢性低氧性高血压大鼠肺循环中RhoA/Rho激酶信号通路的激活。
J Cardiovasc Pharmacol. 2007 Dec;50(6):697-702. doi: 10.1097/FJC.0b013e3181593774.
10
Different response patterns of several ligands at the sphingosine-1-phosphate receptor subtype 3 (S1P(3)).几种配体在鞘氨醇-1-磷酸受体亚型 3(S1P(3))的不同反应模式。
Br J Pharmacol. 2009 Apr;156(8):1305-11. doi: 10.1111/j.1476-5381.2009.00134.x. Epub 2009 Mar 20.

引用本文的文献

1
Molecular heterogeneity in human stroke - What can we learn from the peripheral blood transcriptome?人类中风中的分子异质性——我们能从外周血转录组中学到什么?
J Cereb Blood Flow Metab. 2025 Mar 13:271678X251322598. doi: 10.1177/0271678X251322598.
2
Receptor-dependent effects of sphingosine-1-phosphate (S1P) in COVID-19: the black side of the moon.新冠病毒中鞘氨醇-1-磷酸(S1P)受体依赖性作用:月亮的暗面。
Mol Cell Biochem. 2023 Oct;478(10):2271-2279. doi: 10.1007/s11010-023-04658-7. Epub 2023 Jan 18.
3
S1P receptor modulators and the cardiovascular autonomic nervous system in multiple sclerosis: a narrative review.

本文引用的文献

1
Selectivity and specificity of sphingosine-1-phosphate receptor ligands: caveats and critical thinking in characterizing receptor-mediated effects.鞘氨醇-1-磷酸受体配体的选择性和特异性:表征受体介导效应时的注意事项与批判性思考
Front Pharmacol. 2011 Feb 22;2:9. doi: 10.3389/fphar.2011.00009. eCollection 2011.
2
S1P2 receptor-dependent Rho-kinase activation mediates vasoconstriction in the murine pulmonary circulation induced by sphingosine 1-phosphate.鞘氨醇 1-磷酸诱导的小鼠肺循环血管收缩由 S1P2 受体依赖性 Rho 激酶激活介导。
Am J Physiol Lung Cell Mol Physiol. 2010 Jul;299(1):L137-45. doi: 10.1152/ajplung.00233.2009. Epub 2010 Apr 30.
3
1-磷酸鞘氨醇受体调节剂与多发性硬化症中的心血管自主神经系统:一篇叙述性综述
Ther Adv Neurol Disord. 2022 Nov 22;15:17562864221133163. doi: 10.1177/17562864221133163. eCollection 2022.
4
Pathophysiology and pathogenic mechanisms of pulmonary hypertension: role of membrane receptors, ion channels, and Ca signaling.肺动脉高压的病理生理学和发病机制:膜受体、离子通道和 Ca 信号的作用。
Physiol Rev. 2023 Jul 1;103(3):1827-1897. doi: 10.1152/physrev.00030.2021. Epub 2022 Nov 24.
5
Autoimmunity to Sphingosine-1-Phosphate-Receptors in Systemic Sclerosis and Pulmonary Arterial Hypertension.系统性硬化症和肺动脉高压中鞘氨醇-1-磷酸受体的自身免疫。
Front Immunol. 2022 Jul 4;13:935787. doi: 10.3389/fimmu.2022.935787. eCollection 2022.
6
Preclinical and Clinical Evidence for the Involvement of Sphingosine 1-Phosphate Signaling in the Pathophysiology of Vascular Cognitive Impairment.鞘氨醇 1-磷酸信号在血管性认知障碍病理生理学中的作用的临床前和临床证据。
Neuromolecular Med. 2021 Mar;23(1):47-67. doi: 10.1007/s12017-020-08632-0. Epub 2020 Nov 12.
7
Targeting the SphK-S1P-SIPR Pathway as a Potential Therapeutic Approach for COVID-19.靶向 SphK-S1P-SIPR 通路作为 COVID-19 的一种潜在治疗方法。
Int J Mol Sci. 2020 Sep 29;21(19):7189. doi: 10.3390/ijms21197189.
8
Post-translational modifications of S1PR1 and endothelial barrier regulation.S1PR1 的翻译后修饰与内皮屏障调节。
Biochim Biophys Acta Mol Cell Biol Lipids. 2020 Sep;1865(9):158760. doi: 10.1016/j.bbalip.2020.158760. Epub 2020 Jun 22.
9
A current view of G protein-coupled receptor - mediated signaling in pulmonary hypertension: finding opportunities for therapeutic intervention.肺动脉高压中G蛋白偶联受体介导信号传导的当前观点:寻找治疗干预机会
Vessel Plus. 2018;2. doi: 10.20517/2574-1209.2018.44. Epub 2018 Aug 30.
10
Pulmonary vascular dysfunction secondary to pulmonary arterial hypertension: insights gained through retrograde perfusion.肺动脉高压导致的肺血管功能障碍:逆行灌注获得的认识。
Am J Physiol Lung Cell Mol Physiol. 2018 May 1;314(5):L835-L845. doi: 10.1152/ajplung.00201.2017. Epub 2018 Jan 18.
S1P(5) is required for sphingosine 1-phosphate-induced autophagy in human prostate cancer PC-3 cells.
鞘氨醇-1-磷酸诱导人前列腺癌PC-3细胞自噬需要S1P(5)。
Am J Physiol Cell Physiol. 2009 Aug;297(2):C451-8. doi: 10.1152/ajpcell.00586.2008. Epub 2009 May 27.
4
Regulation of vascular physiology and pathology by the S1P2 receptor subtype.S1P2受体亚型对血管生理和病理的调节作用。
Cardiovasc Res. 2009 May 1;82(2):221-8. doi: 10.1093/cvr/cvp088. Epub 2009 Mar 15.
5
Sphingosine-1-phosphate and modulation of vascular tone.鞘氨醇-1-磷酸与血管张力的调节
Cardiovasc Res. 2009 May 1;82(2):212-20. doi: 10.1093/cvr/cvp064. Epub 2009 Feb 20.
6
Lysophospholipid receptors in vertebrate development, physiology, and pathology.脊椎动物发育、生理学和病理学中的溶血磷脂受体。
J Lipid Res. 2009 Apr;50 Suppl(Suppl):S293-8. doi: 10.1194/jlr.R800047-JLR200. Epub 2008 Dec 8.
7
Sphingosine-1-phosphate: the Swiss army knife of sphingolipid signaling.鞘氨醇-1-磷酸:鞘脂信号传导的瑞士军刀。
J Lipid Res. 2009 Apr;50 Suppl(Suppl):S272-6. doi: 10.1194/jlr.R800065-JLR200. Epub 2008 Nov 5.
8
Regulation of vascular permeability by sphingosine 1-phosphate.1-磷酸鞘氨醇对血管通透性的调节
Microvasc Res. 2009 Jan;77(1):39-45. doi: 10.1016/j.mvr.2008.09.005. Epub 2008 Sep 30.
9
Sphingolipids in the lungs.肺中的鞘脂类
Am J Respir Crit Care Med. 2008 Dec 1;178(11):1100-14. doi: 10.1164/rccm.200804-595SO. Epub 2008 Aug 28.
10
Sphingosine-1-phosphate in the regulation of vascular tone: a finely tuned integration system of S1P sources, receptors, and vascular responsiveness.鞘氨醇-1-磷酸在血管张力调节中的作用:一个由鞘氨醇-1-磷酸来源、受体和血管反应性构成的精细整合系统
Circ Res. 2008 Aug 1;103(3):231-3. doi: 10.1161/CIRCRESAHA.108.181610.